Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

47.99 -0.30 (-0.63%)

Streaming Delayed Price Updated: 2:44 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Volume	1,114,102
Open	48.30
Bid (Size)	47.99 (400)
Ask (Size)	48.00 (300)
Prev. Close	48.30
Today's Range	47.73 - 48.36
52wk Range	30.04 - 49.06
Shares Outstanding	388,132,400
Dividend Yield	1.96%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

Today 0:34 EDT

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Via StockStory

Branded Pharmaceuticals Stocks Q4 Teardown: Royalty Pharma (NASDAQ:RPRX) Vs The Rest

April 07, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...

Via StockStory

Performance

YTD	+23.5%	+23.5%
1 Month	+4.4%	+4.4%
3 Month	+19.2%	+19.2%
6 Month	+32.8%	+32.8%
1 Year	+48.7%	+48.7%

More News

1 Value Stock for Long-Term Investors and 2 Facing Challenges

April 03, 2026

Via StockStory

1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm

March 31, 2026

Via StockStory

Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment ↗

March 27, 2026

Via Chartmill

ROYALTY PHARMA PLC-CL A (NASDAQ:RPRX) Shows High Technical and Setup Ratings Ahead of Potential Breakout ↗

March 18, 2026

Via Chartmill

Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shares Dip Despite Strong Portfolio Growth and 2026 Guidance Beat ↗

February 11, 2026

Via Chartmill

Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases

March 30, 2026

From Royalty Pharma plc

Via GlobeNewswire

The Brain Barrier Broken: Inside Denali Therapeutics’ Landmark FDA Approval of AVLAYAH

March 26, 2026

Via Finterra

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings?

March 25, 2026

Via StockStory

Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence

March 23, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Announces Expansion of Leadership Team

March 17, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

March 02, 2026

From Royalty Pharma plc

Via GlobeNewswire

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

March 02, 2026

From Royalty Pharma plc

Via GlobeNewswire

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

March 02, 2026

From Zymeworks Inc.

Via GlobeNewswire

Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference

February 26, 2026

From Royalty Pharma plc

Via GlobeNewswire

3 Healthcare Stocks Walking a Fine Line

February 18, 2026

Via StockStory

5 Insightful Analyst Questions From Royalty Pharma’s Q4 Earnings Call

February 18, 2026

Via StockStory

Patient Capital Bet Heavily on Chime Financial (CHYM) With a 2.04 Million Share Purchase ↗

February 14, 2026

Via The Motley Fool

Royalty Pharma (RPRX) Q4 2025 Earnings Transcript ↗

February 11, 2026

Via The Motley Fool

Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings

February 11, 2026

Via StockStory

Royalty Pharma Reports Q4 and Full Year 2025 Results

February 11, 2026

From Royalty Pharma plc

Via GlobeNewswire

What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings

February 09, 2026

Via StockStory

3 Mid-Cap Stocks We Keep Off Our Radar

February 05, 2026

Via StockStory

3 Profitable Stocks with Open Questions

January 20, 2026

Via StockStory

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?

Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.

What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?

Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?

The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market

What is the current price of Royalty Pharma plc - Class A Ordinary Shares?

The current price of Royalty Pharma plc - Class A Ordinary Shares is 47.99

When was Royalty Pharma plc - Class A Ordinary Shares last traded?

The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 04/10/26 02:44 PM ET

What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?

The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 18.63B

How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?

Royalty Pharma plc - Class A Ordinary Shares has 19B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.